1.Pharmacologic Therapy for Type 2 Diabetes Mellitus in Childhood.
Journal of Korean Society of Pediatric Endocrinology 2004;9(1):5-10
No abstract available.
Diabetes Mellitus, Type 2*
2.Pathophysiology of Type 2 Diabetes Mellitus.
Journal of Korean Society of Pediatric Endocrinology 2004;9(1):1-4
No abstract available.
Diabetes Mellitus, Type 2*
3.Clinical profile of adult patients with Hyperglycemic Crisis at the De La Salle University Medical Center, a ten-year retrospective study
Andre Luis Agoncillo ; Aimee Andag-Silva ; Daveric Pagsisihan
Philippine Journal of Internal Medicine 2022;60(3):162-168
Abstract:
This current study aims to report the clinical profiles and characteristics of diabetic patients who had been admitted for hyperglycemic crises from 2007 to 2017 at our institution.
Methodology:
We conducted a retrospective study in a tertiary care university hospital outside Metro Manila. The data gathered were divided into three categories: clinical data, biochemical data and precipitating factors.
Results:
A total of 3,120 adult patients with diabetes mellitus were admitted for various reasons, and 71 cases presented with DKA or HHS over the 10-year period of review which is equivalent to 2% of all diabetes mellitus cases admitted. Forty-six (64.79%) of the patients with hyperglycemic crises were known diabetics with a duration of 7-13 years. Majority of patients were not taking anti diabetic medications upon admission. Most patients with hyperglycemic crises were tachycardic and hypertensive upon admission. Majority were discharged and improved. Majority of the cases 53 (81.69%) had DKA. The most common precipitating factor in DKA and HHS was infection.
Conclusion
In conclusion, the biochemical profiles in our series did not significantly differ from the past study by Gatbonton et.al (1998). Despite the advent of new therapies for diabetes mellitus control, mortality among the patients with hyperglycemic crises was slightly higher in our study at 11% compared to the global reported data of 2-10%. One of the reasons could be the minimal improvements in our health care delivery system that is still unable to cater to the needs of diabetic Filipinos. Early screening programs should be done for patients beginning age 40 years and even earlier for those with risk factors for prompt detection and treatment of diabetes mellitus. Education and awareness should be strengthened for patients with diabetes mellitus to avoid the crises by emphasizing the importance of regular follow-up, monitoring and compliance with a diabetic regimen, especially with insulin and multiple OADs (oral anti- diabetic drugs) since the disease is progressive, and timely intensification of therapy is needed.
Diabetes Mellitus, Type 2
4.Diagnostic accuracy of Serum 1,5-anhydroglucitol as a surrogate measure of Glycemic variability among adult Filipinos with Type 2 Diabetes Mellitus: A retrospective cross-sectional study
Ainee Krystelle C. Lee ; Joebeth S. Tabora ; Christian Bernard T Cheng ; Rosa Allyn Sy
Philippine Journal of Internal Medicine 2022;60(4):270-277
Background:
Among the various glycemic indices in current use, glycemic variability has the greatest contribution in the
development of microvascular and macrovascular complications in Type 2 Diabetes mellitus (T2DM). Most metrics that are currently used to measure glycemic variability are derived from continuous glucose monitoring (CGM) data. However, CGM is burdensome to the patient due to its relatively high cost as well as the need for multiple visits with the health care provider. With the use of serum 1,5-anhydroglucitol (1,5-AG) as a biomarker of glucose fluctuations, physicians and patients alike could have an easier surrogate measure of glycemic variability thus aiding in achieving target glucose control. This study
aims to determine the diagnostic accuracy of 1,5-AG as compared to the glycemic variability metrics derived from CGM as a surrogate measure of glycemic variability among adult Filipinos with T2DM.
Methods:
Retrospective analysis of data of adult patients aged 20 years old and above diagnosed with T2DM referred for CGM at the Diabetes, Endocrine, Metabolic, and Nutrition Center of Cardinal Santos Medical Center from January 2017 to October 2021 who underwent serum 1,5-AG level determination within 2 weeks of CGM were collected. Diagnostic accuracy was obtained by computing the sensitivity, specificity, positive (PPV) and negative predictive values (NPV), and Youden index. Pearson correlation coefficient was used to determine the correlation of 1,5-AG and the different metrics. Analysis of variance (ANOVA) was used to check for statistical significance with 99% confidence interval and a p < 0.05 considered as statistically significant.
Results:
This study involving 37 subjects showed a good diagnostic accuracy of serum 1,5-AG levels with the different measures of glycemic variability derived from CGM namely mean amplitude of glycemic excursion (MAGE), continuous overlapping net glycemic action at 1-hour intervals (CONGA-1), and mean of daily differences (MODD) with significant correlation among patients with HbA1c ≤ 7%. Subjects were on CGM for approximately 6 ± 1 day with statistically significant difference between the good and poor glucose control group (p<0.05). Determination of diagnostic accuracy between 1,5- AG and MAGE showed good accuracy (Sensitivity = 95.3%, Specificity = 100%, PPV = 100%, NPV = 75.43%, Diagnostic
accuracy 96%, and a Youden Index of 92.3) with a statistically significant correlation among subjects with HbA1c level ≤ 7% (p=0.021). There is likewise good diagnostic accuracy between CONGA-1 and 1,5-AG level (Sensitivity = 99%, Specificity = 75.29%, PPV = 89.1%, NPV = 97%, Accuracy = 89.50% and Youden index of 58.41) with a statistically significant correlation among subjects with HbA1c ≤ 7% (p=0.038). Comparison with interday glycemic variability showed fair diagnostic accuracy
between MODD and 1,5-AG (Sensitivity = 79.17%, Specificity = 78%, PPV = 97%, NPV = 32%, Accuracy = 76.89%, and Youden index of 49.07) and a statistically significant correlation among subjects with HbA1c ≤ 7% (p=0.009).
Conclusion
There is good diagnostic accuracy of serum 1,5-AG levels with the different measures of glycemic variability derived from CGM namely MAGE, CONGA-1, and MODD with significant correlation among patients with HbA1c ≤ 7%. Among diabetics with HbA1c ≤7%, 1,5-AG could be used as a surrogate measure of glycemic variability and excursions.
Diabetes Mellitus, Type 2
5.The efficacy of daily compared to twice weekly Basal Insulin Titration Algorithms among patients with Type II Diabetes Mellitus: A 12-week randomized controlled trial
Hannah Ruth V. Labajo ; Oliver Allan C. Dampil
Philippine Journal of Internal Medicine 2018;56(3):148-152
Introduction:
There are a significant number of diabetic patients who remain uncontrolled despite basal insulin therapy due to lack of intensification of treatment. Different insulin titration algorithms are recommended by different treatment guidelines. This study compared two basal insulin titration algorithms in terms of time to achieve target glucose, adherence, hypoglycemia episodes, and HbA1c reduction.
Methods:
This is a 12-week randomized clinical trial conducted on insulin-naïve patients with uncontrolled type 2 diabetes mellitus from outpatient clinic of St. Luke’s Medical Center Quezon City. Patients on oral hypoglycemic agent/s with HbA1c seven percent and above were included in the study. They were randomized to either daily titration or twiceweekly insulin titration algorithms using basal insulin glargine.
Results:
Forty-one patients were included in the study. The daily titration algorithm achieved target capillary blood glucose (CBG) at stable insulin dose earlier (33 vs 41.3 days, p-value=0.042) than the twice-weekly titration. Better adherence was also seen among patients on daily titration algorithm as compared to twice weekly (94.94% vs. 91.12%, p-value = 0.009). There was no significant difference in incidence of hypoglycemia (p-value 0.0.62) for both algorithms. All patients from the two groups had significant HbA1c reduction at the end of the study period.
Conclusion
Daily titration algorithm achieved earlier target fasting plasma glucose and better patient adherence as compared to twice-weekly titration in the adjustment of basal insulin dose. HbA1c reduction and risk of hypoglycemia were similar in both titration algorithms.
Diabetes Mellitus, Type 2
6.Single Nucleotide Polymorphism at +276 g>T of the Adiponectin gene and Plasma Adiponectin Level in Myanmar Type 2 Diabetic Patients
Khin Thin Yu ; Kyu Kyu Maung ; Aye Thida ; Thein Myint
Journal of the ASEAN Federation of Endocrine Societies 2018;33(2):160-164
Objective:
The aim of the study was to investigate the association between single nucleotide polymorphisms (SNP) at rs 1501299 (SNP+276 G>T) of the adiponectin gene and plasma adiponectin levels in type 2 diabetes mellitus (T2DM) patients in Myanmar.
Methodology:
One hundred T2DM patients and 104 non-diabetic subjects were included in this cross-sectional analytical study. Genotype frequencies were determined by polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) method. Plasma adiponectin level was measured by enzyme-linked immunosorbent assay (ELISA).
Result:
Genotype frequencies (GG, GT, TT) of SNP+276 in diabetic patients were 39%, 48% and 13%, respectively. The GT and TT genotypes were more frequent in T2DM patients (OR 1.98, 95% CI, 1.10-3.55; p=0.02 and OR 4.07, 95% CI, 1.34-12.3; p=0.01), respectively. The T allele of SNP+276 was significantly associated with T2DM (OR 1.96, 95% CI, 1.27-3.01; p=0.002). Mean plasma adiponectin level was significantly lower than in T2DM patients (27.41±16.7 μg/mL) compared to non-diabetic subjects (37.19±26.77 μg/mL) (p=0.002)
Conclusion
SNP+276 at rs 1501299 of the adiponectin gene was associated with type 2 diabetes and low plasma adiponectin levels in this Myanmar population.
Diabetes Mellitus, Type 2
7.The Effect of DPP4 Inhibitor on Glycemic Variability in Patients with Type 2 Diabetes treated with twice-daily Premixed Human Insulin
Florence Hui Sieng Tan ; Chin Voon Tong ; Xun Ting Tiong ; Bik Kui Lau ; Yueh Chien Kuan ; Huai Heng Loh ; Saravanan A/L Vengadesa Pillai
Journal of the ASEAN Federation of Endocrine Societies 2021;36(2):167-171
Objective:
To evaluate the effect of adding DPP4 inhibitor (DPP4-i) on glycemic variability (GV) in patients with type 2 diabetes mellitus (T2DM) treated with premixed human insulin (MHI).
Methodology:
We conducted a prospective study in patients with T2DM on twice-daily MHI with or without metformin therapy. Blinded continuous glucose monitoring was performed at baseline and following 6 weeks of Vildagliptin therapy.
Results:
Twelve patients with mean (SD) age of 55.8 (13.1) years and duration of disease of 14.0 (6.6) years were recruited. The addition of Vildagliptin significantly reduced GV indices (mmol/L): SD from 2.73 (IQR 2.12-3.66) to 2.11 (1.76-2.55), p=0.015; mean amplitude of glycemic excursions (MAGE) 6.94(2.61) to 5.72 (1.87), p=0.018 and CV 34.05 (8.76) to 28.19 (5.36), p=0.010. In addition, % time in range (3.9-10 mmol/l) improved from 61.17 (20.50) to 79.67 (15.33)%, p=0.001; % time above range reduced from 32.92 (23.99) to 18.50 (15.62)%, p=0.016; with reduction in AUC for hyperglycemia from 1.24 (1.31) to 0.47 (0.71) mmol/day, p=0.015. Hypoglycemic events were infrequent and the reduction in time below range and AUC for hypoglycemia did not reach statistical significance.
Conclusion
The addition of DPP4-I to commonly prescribed twice-daily MHI in patients with T2DM improves GV and warrants further exploration.
Diabetes Mellitus, Type 2
8.Prevalence of Bacterial Urinary Tract Infection among patients With Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter-2 Inhibitors:A prospective real-world setting study
Pankaj Ferwani ; Aasim Maldar ; Nishitkumar Shah ; Phulrenu Chauhan ; Manoj Chadha
Journal of the ASEAN Federation of Endocrine Societies 2022;37(2):5-8
Background:
Genitourinary tract infections, mycotic as well as bacterial, as defined by clinical symptoms, are one of the common adverse effects associated with the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2DM) patients in clinical trials. However, Indian data in terms of the prevalence of culture-proven bacterial type of urinary tract infection (UTI), and the causative organism is limited.
Objective:
This study aimed to determine the prevalence and causative agents of bacterial UTI among patients with T2DM on SGLT2i.
Methodology:
This was a prospective longitudinal study involving all patients with T2DM who were prescribed with SGLT2i, uncontrolled on other oral anti-diabetic medications, from June 2019 to February 2020. Prevalence of bacterial UTI was evaluated at baseline and 12 weeks after initiation of SGLT2i.
Results:
A total of 80 patients were started on SGLT2i. One female patient on canagliflozin had significant asymptomatic bacteriuria and the causative agent was Acinetobacter baumannii. One male patient on dapagliflozin had symptomatic UTI with negative urine culture study. Four patients developed genital mycotic infection.
Conclusion
In this real-world study, SGLT2i as a class, was well tolerated with favorable safety profile, and risk of developing significant bacteriuria and/or symptomatic UTI was minimal.
Diabetes Mellitus, Type 2
9.Effect of Glipizide(Digrin@) in non-insulin-dependent diabetes mellitus
Kyong Soo PARK ; Jae Hoon JUNG ; Kyung Soo KO ; Sung Kwan HONG ; Seong Yeon KIM ; Hong Kyu LEE ; Chang Soon KOH ; Hun Ki MIN
Journal of the Korean Diabetes Association 1991;15(1):103-107
No abstract available.
Diabetes Mellitus, Type 2
10.Correlation on the level of adherence to self-care activities and blood glucose control of adult patients with type 2 diabetes mellitus seen in the Outpatient Department of a tertiary hospital in Baguio City – A cross-sectional study
Jessie James M. Villamin, MD ; Gina Maria A. Retuta MD, FPAFP ; Faith M. Garcia MD, FPAFP ; Joseph L. Alunes MD, FPAFP ; Haydee Danganan MD, FPAFP
The Filipino Family Physician 2023;61(1):94-100
Introduction:
Type 2 Diabetes Mellitus (T2DM) remains one of the leading causes of mortality in the Philippines. Studies have reported that good adherence to self-care activities significantly aid in glycemic control. However, previous studies revealed a low adherence to diabetes self-care activities. Moreover, only few studies were done in the local setting assessing the level of adherence to self-care activities and correlating the two; hence, the immense need for the assessment of level of adherence to self-care activities among patients with T2DM.
Objective:
This study aims to determine the level of adherence to self-care activities and correlate it with the glycemic control among T2DM patients seen in the outpatient department in a tertiary hospital in Baguio City.
Methods:
This cross-sectional study was done using a survey questionnaire adapted from the Summary Diabetes Self-Care Activities Questionnaire version 2000. Glycemic control was determined using the latest valid HbA1c results. One hundred adult diabetic patients were included in the study. Participants were selected in the Family Medicine and Internal Medicine OPD Clinics through systematic random sampling method. Data collected were analyzed using descriptive and inferential statistics.
Results:
Results revealed that majority of the sample population had undesirable self-care activity (69%), and poor glycemic control (69%). Statistical analysis revealed that proper adherence to either exercise (0.003) or compliance to medications (0.012) both have a significant relationship with glycemic control. Overall score (0.003) on one hand revealed a highly significant relationship with glycemic control.
Conclusion
Incorporating the different self-care activities namely diet, exercise, blood sugar testing, foot care, smoking cessation, and compliance to medication all together has a significant relationship with glycemic control among diabetic patients. Clinicians must emphasize proper adherence to self-care activities because of the high number of patients with undesirable self-care activities.
Type 2 diabetes mellitus